Animal Vaccines Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Report Code: ZMR-156 | Report Format : | Status : Upcoming |

Abstract

Vaccination has been one of the most important conciliations in disease prevention that has ever been developed.The effectiveness of vaccination is seen by the reduction in disease.Animal vaccines provide protection against various diseases such as rabies, feline panleukopenia, feline viral rhinotracheitis, feline calicivirus infection, canine distemper, canine parvovirus infection, and canine hepatitis. Hence, most of the animal doctors recommend vaccines depending on the type and severity of the disease.

Animal vaccines can be made available without large, controlled dispute studies that are mandatory prior to the release of human vaccines. Animal vaccines are controlled by the US Department of Agriculture, which hardly requires the vaccines to be shown to be safe and pure, and have a “reasonable expectation” of efficacy prior to their release.Nevertheless, the clinical relevancy or applicability of a particular vaccine may not necessarily be assured by the licensing process. This fact makes it easier for the manufacturers to provide animal vaccines and meet the rising demand in the global market.

Based on the type of vaccine, the global animal vaccines market is segmented as inactivated vaccines, toxoid vaccines, live attenuated vaccines, subunit vaccines, and others. The others segment is further sub-segmented as conjugate vaccines, recombinant vaccines, and DNA vaccines. Of which, the DNA vaccines segment is anticipated to account for the highest growth in the near future. On the basis of disease category, the global market is segmented as anthrax vaccines, rabies vaccine, brucellosis vaccine, DA2PPC vaccine, clostridium vaccine, and others. Based on the product type, the market is further segmented as companion animal, porcine, livestock, equine, poultry, aquaculture, and other animal vaccines. Owing to the rising number of pet owners worldwide, the companion animal segment proves to be largest and the fastest growing segment in the global market.

The growth of global animal vaccines market is expected to boost owing to the increase in the livestock population and frequent occurrence of livestock diseases. In addition, factors such as rising prevalence of zoonotic diseases, various initiatives were taken up by different government agencies and animal associations, and the introduction of new vaccine types also impact the growth of the market in a positive way. Moreover, technological innovations, growing awareness regarding animal health in the emerging countries, etc. are some other factors boosting the market growth.

Asia Pacific is experiencing the highest growth in the global market owing to its increased consumption and trade of meat. This trend is followed by China due to its rising consumption of meat. The global animal vaccines market is dominated by North America followed by Europe and Asia-Pacific.

Major players of the animal vaccines market include Merck Animal Health, Bayer Healthcare Novartis, Bimeda Inc., Ceva Sante Animale, Eli Lilly and Company, and Zoetis. Other key players who dominate the market are Sanofi-Aventis, Boehringer Ingelheim GmbH, and Virbac Inc.

Animal Vaccines Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Thrombus Precursor Protein Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1918 | Report Format:

Global Thrombus Precursor Protein Market: Overview One of the components of the fibrinolytic and coagulation pathways is the thrombus precursor protein (TpP). The thrombus precursor protein acts as a biomarker that specifies the exposure of the people to serious cardiovascular diseases, especial...Read More

Oncology Adjuvants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1914 | Report Format:

Global Oncology Adjuvants Market: Overview Oncology adjuvant treatment is a treatment for the cancer therapy, wherein which after the primary treatment the cancer treatment is involved. The reoccurrence of the cancer is minimized by the oncology adjuvants treatment. The oncology adjuvant therapy...Read More

Limb Salvage Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1911 | Report Format:

Global Limb Salvage Systems Market: Overview The alternative name for the limb salvage is limb sparing surgery. In the case of the bone tumors, this is the surgical procedure that is mostly preferred so that there are no chances of amputations. In the limb salvage surgery, the functional limb im...Read More

Meningococcal Disease Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1899 | Report Format:

Global Meningococcal Disease Treatment Market: Overview Meningococcal disease is a rigorous infection of meninges; in this disease, the membrane of the brain is affected which causes the brain damage. It is caused by Neisseria meningitides bacteria. This bacterium also causes bloodstream infecti...Read More

Injectable Anti-Wrinkle Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1897 | Report Format:

Global Injectable Anti-Wrinkle Market: Overview In order to reduce the wrinkles and the skin lines, people undergo treatment which is known as injectable antiwrinkle treatment where the drugs are injected into the treatment area. It can also make the skin tight and can fill the sagging skin, fro...Read More

Choose License Type:
Latest Published Reports

View All Published Reports